retatrutide approval status october 2025 Compounded Semaglutide vs Wegovy Semaglutide vs Wegovy 2026: Results,

Currently available options in the UK include: Orlistat a licensed oral medication available on prescription or over the counter Semaglutide 2.4 mg (Wegovy) a once-weekly injection approved by NICE (TA875) for eligible patients within a specialist weight management service Tirzepatide (Mounjaro) MHRA-authorised for type 2 diabetes

Tirzepatide activates both the GIP receptor (GIPR) and the GLP-1 receptor (GLP-1R), both class B GPCRs, though with differential potency

A study shows that when used with lifestyle changes, the weekly 2.4 mg dose of semaglutide reduced 10-15% of body weight compared to the placebo, which reduced body weight by only 2-3%

There is no strong evidence that time of day significantly affects absorption, but many researchers prefer morning injections